Evidence map

TrialClinical and experimental nephrology2022

Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study.

Shuichi Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2022
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34837606